• By ICR Secretariat
  • Posted Wednesday, March 27, 2019

Gene therapy progress spurs competition in biotech buyouts

https://www.biopharmadive.com/news/biogen-nightstar-gene-therapy-competition-biotech-buyouts-deal-value/550747/

Drugmakers looking to buy their way into gene therapy are finding healthy competition for promising biotechs, regulatory filings from recent takeovers show, underscoring the renewed momentum behind a field seeking one-time treatments for genetic diseases.